National Cancer Institute
Found 623 results for your search:
Total relevant funding to Non Hodgkins Lymphoma for this search:
$116,691,276
Fiscal Year FY 2016
Cancer Type [Non Hodgkins Lymphoma]
Modify this Search New Search
Close

Modify Search Criteria

Some search criteria may be modified to refine your current search.

Select criteria to modify:

Add or remove search options:

Select criteria above to see additional search options

Cancel
Showing 1 - 50 of 623 results
Clipboard
Project Title Sorted ascending Project Number Funded Amount
Relevant Funding
Principal
Investigator
Institution
1
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition 4R01CA180150-04 $558,328 $558,328 PETROSKI, MATTHEW SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
2
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies 5R01CA185372-03 $321,937 $321,937 RICHARDS, KRISTY CORNELL UNIVERSITY
3
A cohort study among workers exposed to benzene in China ZIA CP010120-02060 $44,764 $8,953 Rothman, Nathaniel DCEG (NCI)
4
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1 ZIA BC 011064 $35,597 $7,119 Mock, Beverly CCR (NCI)
5
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE 3U54CA155496-05S1 $401,250 $108,338 COLDITZ, GRAHAM WASHINGTON UNIVERSITY
6
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma 3R44CA159843-03S1 $94,422 $94,422 BALHORN, RODNEY SHAL TECHNOLOGIES, INC.
7
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose 5R01CA190696-03 $299,009 $299,009 SCHATZ, JONATHAN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
8
A novel NKG2D-specific BiTE cancer immunotherapy 4R01CA164178-04 $336,150 $168,075 SENTMAN, CHARLES DARTMOUTH COLLEGE
9
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease 1R01CA201719-01 $361,499 $180,750 GAMBHIR, SANJIV STANFORD UNIVERSITY
10
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL 1R01CA196266-01A1 $504,843 $504,843 PENICHET, MANUEL UNIVERSITY OF CALIFORNIA LOS ANGELES
11
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL 3R01CA196266-01A1S1 $196,920 $196,920 PENICHET, MANUEL UNIVERSITY OF CALIFORNIA LOS ANGELES
12
A Pathway of Tumor Suppression 4R01CA047296-28 $249,580 $82,361 LOZANO, GUILLERMINA UNIVERSITY OF TX MD ANDERSON CAN CTR
13
A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD 5R44CA192601-02 $467,137 $233,569 FLAIM, JOANN TARGAZYME, INC.
14
A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy 5R44CA192576-02 $417,175 $417,175 BASILE, LENA NEUMEDICINES, INC.
15
A Role for KSHV in the Pathogenesis of Malignancies ZIA SC 010356 $268,745 $26,875 Tosato, Giovanna CCR (NCI)
16
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors 1R21CA198237-01A1 $202,275 $40,455 DANHAUER, SUZANNE WAKE FOREST UNIVERSITY HEALTH SCIENCES
17
Abramson Cancer Center Support Grant 2P30CA016520-40 $7,975,543 $319,022 DANG, CHI UNIVERSITY OF PENNSYLVANIA
18
Abramson Cancer Center Support Grant 3P30CA016520-40S1 $31,250 $1,250 DANG, CHI UNIVERSITY OF PENNSYLVANIA
19
Abramson Cancer Center Support Grant 3P30CA016520-40S2 $499,967 $19,999 DANG, CHI UNIVERSITY OF PENNSYLVANIA
20
Abramson Cancer Center Support Grant 3P30CA016520-40S3 $200,000 $8,000 DANG, CHI UNIVERSITY OF PENNSYLVANIA
21
Activation of Proto-Oncogenes by Chromosomal Translocation ZIA SC 010378 $322,076 $161,038 Aplan, Peter CCR (NCI)
22
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu 5U54CA190152-03 $699,897 $321,953 GOPAL, SATISH UNIV OF NORTH CAROLINA CHAPEL HILL
23
Adult Leukemia Research Center 4P01CA018029-41 $4,225,448 $380,290 APPELBAUM, FREDERICK FRED HUTCHINSON CANCER RESEARCH CENTER
24
AIDS Malignancy Consortium (AMC) 5UM1CA121947-10 $21,619,997 $5,404,999 MITSUYASU, RONALD UNIVERSITY OF CALIFORNIA LOS ANGELES
25
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S1 $1,595,651 $79,783 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
26
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S2 $550,000 $27,500 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
27
Alliance for Clinical Trials in Oncology Operations Center 3U10CA180821-03S3 $750,000 $37,500 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
28
Alliance for Clinical Trials in Oncology Operations Center 5U10CA180821-03 $9,068,022 $453,401 BERTAGNOLLI, MONICA BRIGHAM AND WOMEN'S HOSPITAL
29
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011415 $41,944 $13,842 Kochenderfer, James CCR (NCI)
30
Allotransplant for DOCK8 deficiency ZIA BC 011374 $441,849 $220,925 Hickstein, Dennis CCR (NCI)
31
Alpha Radioimmunotherapy for Lymphoma Treatment 4R01CA172582-04 $634,846 $634,846 SANDMAIER, BRENDA FRED HUTCHINSON CANCER RESEARCH CENTER
32
Alternative End-Joining in DNA Repair and Chromosomal Translocations 5F30CA189740-03 $31,559 $31,559 KUMAR, VIPUL HARVARD MEDICAL SCHOOL
33
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re 5R42CA183708-05 $133,116 $133,116 PARSONS, CHRISTOPHER APOGEE BIOTECHNOLOGY CORPORATION
34
Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma 1K22CA197014-01 $194,616 $194,616 YANG, YIBIN RESEARCH INST OF FOX CHASE CAN CTR
35
Anatomic Pathology Residency Program ZIE BC 011384 $1,014,935 $81,195 Barr, Frederic CCR (NCI)
36
Animal Model and Genotyping Core Support Facility ZIC BC 011047 $1,011,302 $202,260 DuBois, Wendy CCR (NCI)
37
Annual International Primary CNS Lymphoma Collaborative Group Meeting 2R13CA124293-09 $2,500 $2,500 BATCHELOR, TRACY MASSACHUSETTS GENERAL HOSPITAL
38
Anticancer drug-induced BH3-only protein.Bak interactions 4R01CA166741-05 $329,925 $329,925 KAUFMANN, SCOTT MAYO CLINIC ROCHESTER
39
Antigen-specific T cell Redirectors, ATR, for immunotherapy 5R21CA185819-02 $211,410 $211,410 SCHNECK, JONATHAN JOHNS HOPKINS UNIVERSITY
40
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma 2R44CA144104-04 $1,053,521 $1,053,521 KLINGHOFFER, RICHARD PRESAGE BIOSCIENCES, INC.
41
ATBC Study ZIA CP010195-03031 $1,193,520 $95,482 Albanes, Demetrius DCEG (NCI)
42
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor ZIA BC 011413 $167,778 $167,778 Kochenderfer, James CCR (NCI)
43
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research ZIG BC 010856 $14,732,997 $736,650 Custer, Mary CCR (NCI)
44
BCR Signaling in ABC DLBCL ZIA BC 011354 $107,270 $107,270 Wilson, Wyndham CCR (NCI)
45
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins ZIA BC 010030 $791,464 $39,573 Ambudkar, Suresh CCR (NCI)
46
Biochemical Basis of T Cell Activation ZIA BC 010304 $1,437,752 $718,876 Samelson, Lawrence CCR (NCI)
47
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda 5U54CA190146-03 $693,281 $201,051 CASPER, COREY FRED HUTCHINSON CANCER RESEARCH CENTER
48
Biology and Transplantation of the Hematopoietic Stem Cell 5P01CA065493-22 $1,914,901 $210,639 WAGNER, JOHN UNIVERSITY OF MINNESOTA
49
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis ZIA BC 011334 $353,472 $17,674 Kaplan, Rosandra CCR (NCI)
50
Biomarkers of benzene exposure ZIA CP010121-02035 $52,989 $18,016 Rothman, Nathaniel DCEG (NCI)
Total relevant funding to Non Hodgkins Lymphoma for this search: $116,691,276
Showing 1 - 50 of 623 results
Go to top